# NIH Reporter #1U01FD009015-01

Clinical and Usability Validation of Gait Velocity (SV95C) Measured from Wearable Digital Sensors

**Recipient:** Massachusetts General Hospital

**Award Amount:** $878,203.00
**Ceiling:** $878,203.00

**Awarded:** September 23, 2026

**Identifier:** 1U01FD009015-01

The FDA-funded project will assess whether wearable sensor-measured SV95C can serve as a meaningful efficacy endpoint in ALS clinical trials.

### Description

A project to validate the clinical trial readiness of Stride Velocity 95th Centile (SV95C), a wearable-derived gait measure, in patients with amyotrophic lateral sclerosis (ALS), including assessment of its validity, responsiveness, clinical meaning, and usability.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11622545)